FDA Inspection 1116855 — Azzouzi, Abdel-Rahmene
The FDA completed an inspection of Azzouzi, Abdel-Rahmene on December 6, 2019 in Angers. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 6, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Angers (France)
Additional Details
Clinical Investigator (CI)